Identifying and controlling infectious diseases spread by animals and insects in Uganda
Official title: CK19-001 - Identification, Surveillance, and Control of Vector-Borne and Zoonotic Infectious Diseases in Uganda
Funded at Uganda Virus Research Institute · NIH-11140942 · Data updated 2026-11-12
This study is working to find better ways to spot and control diseases spread by insects and animals in Uganda, like Crimean Congo Hemorrhagic Fever and Yellow Fever, so that people can stay healthier and avoid outbreaks.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Uganda Virus Research Institute NIH-funded |
| Lab location | 1 site (Entebbe, Uganda) |
| Project start | September 1, 2019 |
| Project end | August 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $992,830 |
| NIH project number | 6U01CK000564-05M001 |
| Project ID | NIH-11140942 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals living in Uganda who are at risk of vector-borne and zoonotic diseases.
✕Less likely to help
Patients living outside of Uganda or those not exposed to vector-borne or zoonotic diseases may not receive any benefit from this research.
What this research studies
This research focuses on the identification, surveillance, and control of infectious diseases that are transmitted by vectors like insects and zoonotic diseases that come from animals in Uganda. The project aims to establish effective diagnostic and monitoring systems to detect and manage outbreaks of diseases such as Crimean Congo Hemorrhagic Fever, Rift Valley Fever, and Yellow Fever. By implementing coordinated programs for disease detection and risk assessment, the research seeks to prevent the spread of these infections at an early stage. Patients in Uganda may benefit from improved health outcomes as a result of better disease management and prevention strategies.
Why it matters
Potential benefit: If successful, this research could lead to more effective prevention and control of infectious diseases in Uganda, ultimately saving lives.
How similar studies have gone: Previous research has shown success in implementing similar surveillance and control measures for infectious diseases in other regions, indicating the potential effectiveness of this approach.
Where this research is happening
-
Uganda Virus Research Institute
Entebbe, Uganda Active
Researchers
- Principal investigator: Lutwama, Julius Julian — Uganda Virus Research Institute
- Study coordinator: Lutwama, Julius Julian
Related research
Other NIH-funded projects on the same topics.
-
Uganda Schistosomiasis Multidisciplinary Research Center
A Uganda-based research program aims to understand why some people get more severe schistosomiasis and to find better ways to prevent and control it for communities in Uganda and similar regions.
-
Ugandan Schistosomiasis Research Center exploring why some people get severe disease
Scientists in Uganda are studying how Schistosoma mansoni causes serious illness and how to prevent it, focusing on both children and adults in high-risk areas.
-
Detecting and stopping animal- and insect-transmitted infections in Uganda
A program in Uganda to strengthen testing, tracking, and rapid response for infections passed from animals or insects to protect affected communities.
-
Identifying and controlling infectious diseases spread by animals and insects in Uganda
This study is working to improve how we find and manage diseases spread by insects and animals in Uganda, so that people can get quicker help and stay healthier during outbreaks like Crimean Congo Hemorrhagic Fever and Rift Valley Fever.
-
Using data science to understand blood cell traits and disease risk in Africa
This study is looking at genetic information from blood cells to find new genes that could help predict health risks for people of African descent, aiming to improve understanding of how genetics affect conditions like heart and infectious diseases.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.